Skip to main content
An official website of the United States government
Español
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

BB-10901

A substance being studied in the treatment of some types of cancer, including Wilms tumor, neuroblastoma, rhabdomyosarcoma, and other types of soft tissue sarcoma. BB-10901 contains a monoclonal antibody that binds to a protein called CD56 on some types of cancer cells. It also contains an anticancer drug called DM1, which may help kill cancer cells after BB-10901 binds to them. BB-10901 is a type of antibody-drug conjugate. Also called lorvotuzumab mertansine.
Search NCI's Dictionary of Cancer Terms